牛牛AI助理已提取核心訊息
Jessica Edgar Morris, the Chief Operating Officer of Tonix Pharmaceuticals Holding Corp. (TNXP), was involved in a transaction on February 27, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key executive of the company, any trading activity by Morris is closely watched by investors for insights into executive confidence and potential future performance of the company's stock.
Jessica Edgar Morris, the Chief Operating Officer of Tonix Pharmaceuticals Holding Corp. (TNXP), was involved in a transaction on February 27, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key executive of the company, any trading activity by Morris is closely watched by investors for insights into executive confidence and potential future performance of the company's stock.
Tonix Pharmicals Holding Corp.（TNXP）首席運營官傑西卡·埃德加·莫里斯於2024年2月27日參與了一筆交易。該交易的具體細節，包括行動類型、狀態、股票數量、股票性質、交易價格和交易後持有量，未在公告中披露。作爲公司的主要高管，莫里斯的任何交易活動都受到投資者的密切關注，以深入了解公司股票的高管信心和潛在的未來表現。
Tonix Pharmicals Holding Corp.（TNXP）首席運營官傑西卡·埃德加·莫里斯於2024年2月27日參與了一筆交易。該交易的具體細節，包括行動類型、狀態、股票數量、股票性質、交易價格和交易後持有量，未在公告中披露。作爲公司的主要高管，莫里斯的任何交易活動都受到投資者的密切關注，以深入了解公司股票的高管信心和潛在的未來表現。
有用
沒用